The Major Histocompatibility Complex–related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its Lifespan

Cited by (642)

Items 401–500 of 642

1. Functionalized FcRn-targeted nanosystems for oral drug delivery: A new approach to colorectal cancer treatment
   Fatima Hameedat, Nuria A. Pizarroso, Natália Teixeira, Soraia Filipa Tavares Pinto, Bruno Filipe Carmelino Cardoso Sarmento · 2022 · European Journal of Pharmaceutical Sciences
2. Addition of a sequence from α2-antiplasmin transforms human serum albumin into a blood clot component that speeds clot lysis
   William P. Sheffield, Louise J. Eltringham‐Smith, Sharon Gataiance, Varsha Bhakta · 2009 · BMC Biotechnology
3. Single protein encapsulated SN38 for tumor-targeting treatment
   Changjun Yu, Faqing Huang, Kinsley Wang, Mengmeng Liu, Warren Allen Chow, Xiang Ling, Fengzhi Li, Jason Causey, Xiuzhen Huang, Galen Cook‐Wiens et al. · 2023 · Journal of Translational Medicine
4. The role of immunoglobulin transport receptor, neonatal Fc receptor in mucosal infection and immunity and therapeutic intervention
   Shaoju Qian, Danqiong Zhang, Zishan Yang, Ruixue Li, Xuehan Zhang, Feifei Gao, Lili Yu · 2024 · International Immunopharmacology
5. A fully humanized von Willebrand disease type 1 mouse model as unique platform to investigate novel therapeutic options
   Geneviève McCluskey, Marco Heestermans, Ivan Peyron, E Pascal, Marie-Annick A Clavel, Eric Bun, Emilie Bocquet, Christelle Repérant, Sophie Susen, Olivier D. Christophe et al. · 2024 · Haematologica
6. Human serum albumin-3-amino-1-propanesulfonic acid conjugate inhibits amyloid-β aggregation and mitigates cognitive decline in Alzheimer's disease
   Divya Shastri, Chaitany Jayprakash Raorane, Vinit Raj, Sang-Kil Lee · 2025 · Journal of Controlled Release
7. Propensities of Fatty Acid-Modified ASOs: Self-Assembly vs Albumin Binding
   Eric-André Kusznir, Jean-Christophe Hau, Michaela Portmann, Anne-Gaëlle Reinhart, Fabio Falivene, Jessica Bastien, Jesper Worm, Alfred Ross, Matthias E. Lauer, Philippe Ringler et al. · 2023 · Bioconjugate Chemistry
8. Polymorphisms of Neonatal Fc Receptor in Cynomolgus and Rhesus Macaques
   Yasuhiro Uno, Masahiro Utoh, Kazuhide Iwasaki · 2014 · Drug Metabolism and Pharmacokinetics
9. Single chain antibody fragments with pH dependent binding to FcRn enabled prolonged circulation of therapeutic peptide in vivo
   Yangsheng Qiu, Wei Lv, Min Xu, Yuhong Xu · 2016 · Journal of Controlled Release
10. Are filtered plasma proteins processed in the same way by the kidney?
    Wayne Doveton Comper, Leileata M. Russo, Julijana Vuchkova · 2016 · Journal of Theoretical Biology
11. Somatic cell count–based selection reduces susceptibility to energy shortage during early lactation in a sheep model
    Juliette Bouvier-Muller, Charlotte Allain, Francis Enjalbert, Yves Farizon, David Portes, Gilles Foucras, Rachel Rupp · 2018 · Journal of Dairy Science
12. Solution structures of long-acting insulin analogues and their complexes with albumin
    Line Abildgaard Ryberg, Pernille Sønderby, Fabian Barrientos, Jens T. Bukrinski, Günther Herbert Johannes Peters, Pernille Harris · 2019 · Acta Crystallographica Section D Structural Biology
13. An engineered serum albumin-binding AAV9 capsid achieves improved liver transduction after intravenous delivery in mice
    Quan Jin, Chunping Qiao, Jianbin Li, Juan Li, Xiao Xiao · 2019 · Gene Therapy
14. In vitro and in vivo evaluation of a non-carbohydrate targeting platform for lysosomal proteins
    James E. Stefano, Lihui Hou, Denise M. Honey, Josephine Kyazike, Anna Park, Qun Zhou, Clark Q. Pan, Tim Edmunds · 2008 · Journal of Controlled Release
15. Optimizing Anti-PD1 Immunotherapy: An Overview of Pharmacokinetics, Biomarkers, and Therapeutic Drug Monitoring
    Joaquim Monteiro, Alexandrina Fernandes, Diogo Gavina Tato, Elias Moreira, Ricardo Jorge Teixeira Ribeiro, Henrique Reguengo, Jorge Gonçalves, Paula Fresco · 2025 · Cancers
16. Albumin-based nanocarriers: Singularities, synthesis methods, clinical relevance and targeting strategies in cancer
    Edgar Pérez‐Herrero, Alberto Fernández‐Medarde, Juan M. Irache · 2025 · Acta Pharmaceutica Sinica B
17. HLA-DQ8 Supports Development of Insulitis Mediated by Insulin-Reactive Human TCR-Transgenic T Cells in Nonobese Diabetic Mice
    Jeremy J. Racine, Adel Misherghi, Jennifer R. Dwyer, Richard S. Maser, Elvira Forte, Olivia Bedard, Susanne Sattler, Alberto Pugliese, Laurie G. Landry, Colleen M. Elso et al. · 2023 · The Journal of Immunology
18. Structural design of the anti-TNFα therapeutic NANOBODY® compound, ozoralizumab, to support its potent and sustained clinical efficacy
    Masashi Mima, Chiemi Mishima-Tsumagari, Koichiro Nakano, M. S. S. Morimoto, Hitoshi Ogata, Mayumi Sakata, Ryo Iwaoka, Katsuya Iwata, Kenji Hachiuma, Kunihiko Iwamoto et al. · 2024 · Biochemical and Biophysical Research Communications
19. Selection of Nanobodies that Target Human Neonatal Fc Receptor
    Jan Terje Andersen, María González-Pajuelo, Stian Foss, Ole J.B. Landsverk, Débora Pinto, Alexander Szyroki, Hans de Haard, Michael John Saunders, Peter Vanlandschoot, Inger Sandlie · 2013 · Scientific Reports
20. A Silicone Oil-Free Syringe Tailored for Intravitreal Injection of Biologics
    Torleif Tollefsrud Gjølberg, Heidrun Elisabeth Lode, Gustavo Barreto Melo, Simone Mester, Christine Probst, Magne Sand Sivertsen, Øystein Kalsnes Jørstad, Jan Terje Andersen, Morten C. Moe · 2022 · Frontiers in Ophthalmology
21. Association of beta-2-microglobulin with cardiovascular and all-cause mortality in the general and non-CKD population
    Hang Fang, Qiankun Zhang, Lie Jin · 2023 · Medicine
22. Coagulation Factor X Interaction with Macrophages through Its N-Glycans Protects It from a Rapid Clearance
    Mohamad Kurdi, Ghislaine Chérel, Peter J. Lenting, Cécile V. Denis, Olivier D. Christophe · 2012 · PLoS ONE
23. Pharmacokinetics, exposure, efficacy and safety of obinutuzumab in rituximab‐refractory follicular lymphoma patients in the GADOLIN phase III study
    Ekaterina Gibiansky, Leonid V. Gibiansky, Vincent Buchheit, Nicolas Frey, Michael Brewster, Günter Fingerle‐Rowson, Candice Jamois · 2019 · British Journal of Clinical Pharmacology
24. Macrophage receptor SR-AI is crucial to maintain normal plasma levels of coagulation factor X
    Vincent Muczynski, Amine Bazaa, Cécile Loubière, Amélie Harel, Ghislaine Chérel, Cécile V. Denis, Peter J. Lenting, Olivier D. Christophe · 2015 · Blood
25. Impacts of cachexia progression in addition to serum IgG and blood lymphocytes on serum nivolumab in advanced cancer patients
    Kazuki Abe, Kaito Shibata, Takafumi Naito, Atsushi Otsuka, Masato Karayama, Masato Maekawa, Hideaki Miyake, Takafumi Suda, Junichi Kawakami · 2021 · European Journal of Clinical Pharmacology
26. Albumin Biomolecular Drug Designs Stabilized through Improved Thiol Conjugation and a Modular Locked Nucleic Acid Functionalized Assembly
    Anders Dinesen, Alexander Winther, Archie Wall, Anders Märcher, Johan Palmfeldt, Vijay Chudasama, Jesper Wengel, Kurt V. Gothelf, James R. Baker, Kenneth Alan Howard · 2022 · Bioconjugate Chemistry
27. Improving Management of Portal Hypertension: The Potential Benefit of Non-Etiological Therapies in Cirrhosis
    Niccolò Bitto, Gabriele Ghigliazza, Stanislao Lavorato, Camilla Caputo, Vincenzo La Mura · 2023 · Journal of Clinical Medicine
28. A precisely humanized FCRN transgenic mouse for preclinical pharmacokinetics studies
    Christopher M. Conner, Donald Van Fossan, Kristen Read, Dale O. Cowley, Oscar Alvarez, Shannon Xiang-Ru Xu, David R. Webb, Kurt Jarnagin · 2023 · Biochemical Pharmacology
29. Abundant Intracellular IgG in Enterocytes and Endoderm Lacking FcRn
    Sudhasri Mohanty, Jonghan Kim, Latha Prabha Ganesan, Gary S. Phillips, John M. Robinson, Clark L. Anderson · 2013 · PLoS ONE
30. Protein modification by thiolactone homocysteine chemistry: a multifunctionalized human serum albumin theranostic
    Tatyana V. Popova, Olesya A. Krumkacheva, Anna S. Burmakova, Anna S. Spitsyna, Olga D. Zakharova, Vladimir A. Lisitskiy, Igor A. Kirilyuk, Vladimir N. Silnikov, Michael K. Bowman, Elena G. Bagryanskaya et al. · 2020 · RSC Medicinal Chemistry
31. An In Vivo Model of Echovirus-Induced Meningitis Defines the Differential Roles of Type I and Type III Interferon Signaling in Central Nervous System Infection
    Alexandra I. Wells, Carolyn B. Coyne · 2022 · Journal of Virology
32. Variations in Serum Hemoglobin, Albumin, and Electrolytes in Patients Receiving Intravenous Immunoglobulin Therapy
    Michele Davide Mignogna, Giulio Fortuna, Elvira Ruoppo, Daniela Adamo, Stefania Leuci, Stefano Fedele · 2007 · American Journal of Clinical Dermatology
33. Antibody fragments as therapeutics
    2012 · Elsevier eBooks
34. Presence of the di-leucine motif in the cytoplasmic tail of the pig FcRn α chain
    Yaofeng Zhao, Imre Kacskovıcs, Zhihui Zhao, Lennart L G Hammarström · 2003 · Veterinary Immunology and Immunopathology
35. Advancing Animal Models of Human Type 1 Diabetes
    DAVID V. SERREZE, Jennifer R. Dwyer, Jeremy J. Racine · 2024 · Cold Spring Harbor Perspectives in Medicine
36. RNA-encoded Interleukin 2 with Extended Bioavailability Amplifies RNA Vaccine–Induced Antitumor T-cell Immunity
    Daniel Peters, Lena M. Kranz, David Eisel, Mustafa Diken, Sebastian Kreiter, Özlem Türeci, Uğur Şahin, Mathias Vormehr · 2024 · Cancer Immunology Research
37. Porcine Epidemic Diarrhea Virus nsp13 Protein Downregulates Neonatal Fc Receptor Expression by Causing Promoter Hypermethylation through the NF-κB Signaling Pathway
    Xiangchao Jia, Jing Chen, Chenyuan Qiao, Chenxi Li, Kang Yang, Yang Zhang, Jian Li, Zili Li · 2023 · The Journal of Immunology
38. A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery
    Sopisa Benjakul, Aina Karen Anthi, Anette Kolderup, Marina Vaysburd, Heidrun Elisabeth Lode, Donna L. Mallery, Even Fossum, Elisabeth Lea Vikse, Anna Albecka, Aleksandr Ianevski et al. · 2023 · PNAS Nexus
39. A novel synthetic bipartite carrier protein for developing glycotope-based vaccines
    Hsiao‐Ling Chiang, Chi‐Yu Lin, Fan-Dan Jan, Yaoh-Shiang Lin, Chia-Tse Hsu, Jacqueline Whang‐Peng, Leroy F. Liu, Shin Nieh, Chun‐Cheng Lin, Jaulang Hwang · 2012 · Vaccine
40. Incorporation of albumin fusion proteins into fibrin clots in vitro and in vivo: comparison of different fusion motifs recognized by factor XIIIa
    William P. Sheffield, Louise J. Eltringham‐Smith · 2011 · BMC Biotechnology
41. The expression and function of the neonatal Fc receptor in thyrocytes of Hashimoto's thyroiditis
    Chenxu Zhao, Ying Gao, Lanlan Zhao, Yuan Li, Yang Zhang, Suxia Wang, Hong Zhang, Guizhi Lu, Xiaohui Guo · 2017 · International Immunopharmacology
42. The Role of Proximal Tubular Cells in the Early Stages of Diabetic Nephropathy
    Giovani Bravin Peres · 2015 · Journal of Diabetes & Metabolism
43. Pharmacokinetic drug evaluation of albutrepenonacog alfa (CSL654) for the treatment of hemophilia
    Massimo Morfini · 2016 · Expert Opinion on Drug Metabolism & Toxicology
44. The endosomal system of primary human vascular endothelial cells and albumin–FcRn trafficking
    Andreas Pannek, Janine Becker-Gotot, Steven Dower, Anne M. Verhagen, Paul A. Gleeson · 2023 · Journal of Cell Science
45. Enhanced therapeutic potential of antibody fragment via IEDDA-mediated site-specific albumin conjugation
    Eun Byeol Go, Jae Hun Lee, Jeong Haeng Cho, Na Hyun Kwon, Jong‐il Choi, Inchan Kwon · 2024 · Journal of Biological Engineering
46. Maternal IgE Influence on Fetal and Infant Health
    Jozef Balla, Abhay P. S. Rathore, Ashley L. St. John · 2025 · Immunological Reviews
47. Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications
    Yuyang Song, Laura A. Bienvenu, Viktoria Bongcaron, Shania A Prijaya, Ana C. Maluenda, Aidan P. G. Walsh, James D. McFayden, Geoffrey A. Pietersz, Karlheinz Peter, Xiaowei Wang · 2024 · Theranostics
48. Cellular Neonatal Fc Receptor Recycling Efficiencies can Differentiate Target-Independent Clearance Mechanisms of Monoclonal Antibodies
    Mark A. Bryniarski, Md Tariqul Haque Tuhin, Timothy M. Acker, Devin L. Wakefield, Panijaya Sethaputra, Kevin D. Cook, Marcus Soto, Manuel Ponce, Ronya Primack, Aditya Jagarapu et al. · 2024 · Journal of Pharmaceutical Sciences
49. Development of a predictive algorithm for the efficacy of half-life extension strategies
    Patrick M. Glassman · 2024 · International Journal of Pharmaceutics
50. Non-neutralizing Antibodies May Contribute to Suppression of SIVmac239 Viremia in Indian Rhesus Macaques
    Núria Pedreño-López, Brandon C. Rosen, Walter J. Flores, Matthew J. Gorman, Thomas B. Voigt, Michael J. Ricciardi, Kristin Crosno, Kim L. Weisgrau, Christopher L. Parks, Jeffrey D. Lifson et al. · 2021 · Frontiers in Immunology
51. The MHC class I-related FcRn ameliorates murine Lyme arthritis
    Helena Crowley, Joseph Alroy, Thomas J. Sproule, Derry C. Roopenian, Brigitte T. Huber · 2006 · International Immunology
52. Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells
    Tiziana Alberio, Greta Forlani, Marta Lualdi, Giovanna Tosi, Roberto Sergio Accolla, Mauro Fasano · 2018 · Journal of Translational Medicine
53. Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activityin vivo
    Sandra Wymann, Marcel Mischnik, David Leong, Subhajit Ghosh, Xiahui Tan, Helen Cao, Benjamin Kuehnemuth, Glenn A. Powers, Partho Halder, Mitchell J. de Souza et al. · 2022 · Biochemical Journal
54. Channels across Endothelial Cells
    Radu V. Stan · 2007 · Springer eBooks
55. Half‐Life Extension by Fusion to Recombinant Albumin
    Hubert J. Metzner, Thomas Weimer, Stefan Schulte · 2012
56. Identification of a direct interaction between the Fab domains of IgG antibodies and human FcRn upon IgG-FcRn complex formation
    Esben Trabjerg, Jeannette Nilsen, Torleif Tollefsrud Gjølberg, Jan Terje Andersen, Alexander Leitner, Kasper Dyrberg Rand · 2025 · Communications Biology
57. Prediction of Belimumab Pharmacokinetics in Chinese Pediatric Patients with Systemic Lupus Erythematosus
    Xuan Zhou, Tsung-I Lee, Min Zhu, Peiming Ma · 2021 · Drugs in R&D
58. A versatile insertion point on albumin to accommodate peptides and maintain their activities
    Zhiwei Huang, Huajian Lin, Shujuan Yu, Hanlin Li, Yang Zhou, Yuan Cheng, Shanli Chen, Cai Yuan, Mingdong Huang · 2022 · International Journal of Biological Macromolecules
59. Computation-Aided Design of Albumin Affibody-Inserted Antibody Fragment for the Prolonged Serum Half-Life
    Na Hyun Kwon, Jae Hun Lee, Inchan Kwon · 2022 · Pharmaceutics
60. Delamanid proliposomal powder aerosols targeting alveolar macrophages for treatment of pulmonary extensively drug-resistant tuberculosis treatment: Bioactivity, biocompatibility, and structure elucidation
    Krittawan Tongkanarak, Himanshu Paliwal, Titpawan Nakpheng, Muhammad Ali Khumaini Mudhar Bintang, Teerapol Srichana · 2024 · Journal of Drug Delivery Science and Technology
61. Novel therapeutic approach for psoriasis: Upregulating FcRn to inhibit ferroptosis and alleviate lesional skin
    Shaoju Qian, Zishan Yang, Xingyi Zhang, Ruixue Li, Yujie Sun, Zihan Zhang, Yeqing He, Yihang Song, Zhou Tang, Junrui Ding et al. · 2024 · Free Radical Biology and Medicine
62. Single Protein Encapsulated Doxorubicin as an Efficacious Anticancer Therapeutic
    Changjun Yu, Faqing Huang, Warren Allen Chow, Galen Cook‐Wiens, Xiaojiang Cui · 2020 · Advanced Therapeutics
63. Clostridium butyricum CB1 up-regulates FcRn expression via activation of TLR2/4-NF-κB signaling pathway in porcine small intestinal cells
    Chenxi Li, Rui Cao, Shaoju Qian, Chenyuan Qiao, Xi Liu, Zutao Zhou, Zili Li · 2021 · Veterinary Immunology and Immunopathology
64. Two-Step Preparation of Protein-Decorated Biohybrid Quantum Dot Nanoparticles for Cellular Uptake
    Agata Noelia Traverso, David José Fragale, Diego Luis Viale, Octavio Federico Garate, Pablo Torres, Gastón Valverde, Alejandro Berra, V. Torbidoni, Juan Sebastián Yakisich, Mariano Grasselli et al. · 2023 · Pharmaceutics
65. Alternative Scaffolds: Expanding the Options of Antibodies
    Andreas Plückthun · 2009 · Cambridge University Press eBooks
66. Toward Understanding the Molecular Recognition of Albumin by p53-Activating Stapled Peptide ATSP-7041
    Garima Tiwari, Chandra Shekhar Verma · 2017 · The Journal of Physical Chemistry B
67. Short FcRn-Binding Peptides Enable Salvage and Transcytosis of scFv Antibody Fragments
    Vince W. Kelly, Shannon J. Sirk · 2022 · ACS Chemical Biology
68. Inter‐regional pharmacokinetics and exposure–response analyses of belimumab in patients with system lupus erythematosus
    Junyi Wu, Xuan Zhou, Richard J. Dimelow, Scott F. Marshall · 2024 · British Journal of Clinical Pharmacology
69. Site-Selectively Functionalized Albumin with DFO*Maleimide for 89Zr-Radiolabeling Yields a Metabolically Stable PET Probe that Enables Late Time-Point Tumor Imaging in Mice
    Julia Kronberger, Theresa Balber, Hemma Henrike Schueffl, Raphaela Wahrmann, Anja Federa, Mathias Gradl, Marie Brandt, Thomas Wanek, Markus Mitterhauser, Christian R. Kowol et al. · 2025 · Journal of Medicinal Chemistry
70. Human serum albumin binds spike protein and protects cells from SARS-CoV-2 infection by modulating the RAS pathway
    Romualdo Varricchio, Giovanna De Simone, Gian Marco Vita, Walter Nocera Cariola, Maurizio Viscardi, Sergio Brandi, Gerardo Picazio, Verena Zerbato, R. Koncan, Ludovica Segat et al. · 2023 · Aspects of Molecular Medicine
71. Engineering of long-acting human growth hormone-Fc fusion proteins: Effects of valency, fusion position, and linker design on pharmacokinetics and efficacy
    Taekyeol Lee, D.Y Lee, Eunee Jung, Mi-Kyung Son, Kyohwan Koo, Jae‐Hoon Choi · 2025 · PLoS ONE
72. Study on FcγRn Electrochemical Receptor Sensor and Its Kinetics
    Dandan Peng, Dingqiang Lu, Guangchang Pang · 2020 · Molecules
73. Engineering a “three-in-one” hirudin prodrug to reduce bleeding risk: A proof-of-concept study
    Yuanjun Zhu, Hu-Hu Han, Lin Zhai, Yi Yan, Xiaoyan Liu, Yinye Wang, Liandi Lei, Jiancheng Wang · 2021 · Journal of Controlled Release
74. An Expanded Genome-Wide Association Study of Fructosamine Levels Identifies RCN3 as a Replicating Locus and Implicates FCGRT as the Effector Transcript
    Fernando Riveros-Mckay, David J. Roberts, Emanuele Di Angelantonio, Bing Yu, Nicole Soranzo, John Danesh, Elizabeth Selvin, Adam S. Butterworth, Inês Barroso · 2021 · Diabetes
75. Utilization of endogenous albumin trafficking pathways in the lungs has potential to modestly increase the lung interstitial access and absorption of drug delivery systems after inhaled administration
    Jibriil Ibrahim, Neville J. Butcher, Ashok Kothapalli, Christopher N. Subasic, Joanne T. Blanchfield, Andrew K. Whittaker, Michael Raymond Whittaker, Lisa M. Kaminskas · 2023 · Expert Opinion on Drug Delivery
76. Exploiting the neonatal crystallizable fragment receptor to treat kidney disease
    James F. Dylewski, George Haddad, Judith Tamara Blaine · 2023 · Kidney International
77. Associations between serum albumin and serious non-AIDS events among people living with HIV
    Andreas Ronit, Camilla Ingrid Hatleberg, Lene Ryom, Fabrice Bonnet, Wafaa M. El-Sadr, Peter Reiss, Rainer Weber, Christian Pradier, Stéphane De Wit, Matthew G. Law et al. · 2018 · AIDS
78. Renal Filtration, Transport, and Metabolism of Albumin and Albuminuria
    Wayne Doveton Comper, Tanya M. Osicka, Leileata M. Russo · 2008 · Elsevier eBooks
79. Recombinant Albumin Fusion Proteins
    Thomas Weimer, Hubert J. Metzner, Stefan Schulte · 2013
80. Defective lymphangiogenesis and iron removal after hemarthrosis in factor VIII-deficient mice are rectified with therapeutic factor VIII administration—implications for joint health
    Bilgimol Chumappumkal Joseph, Juan A. De Pablo-Moreno, Nicca Falah, Mia Lora Cacho, Annette von Drygalski · 2025 · Journal of Thrombosis and Haemostasis
81. Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties
    Kristin Hovden Aaen, Maria Francesca Testa, Jeannette Nilsen, Rebecca Tarantino, Cesare Canepari, Mascia Benedusi, Sopisa Benjakul, Mari Nyquist-Andersen, Marie Leangen Herigstad, Alessio Cantore et al. · 2025 · Nature Communications
82. Structure of the human astrovirus capsid spike in complex with the neonatal Fc receptor
    Adam Lentz, Sarah Lanning, Khurshid R. Iranpur, Lena Ricemeyer, Carlos Federico Arias, Rebecca M. DuBois · 2025 · Nature Communications
83. Nanobody–chlorin e6 conjugate for Nectin‐4‐mediated tumor targeting and enhanced photodynamic therapy
    Haodian Wan, Tao Ye, Yawei Bi, Jiayu Zhang, Wei Wu, Aochi Liu, Li Sun, Jie Lin, Ningli Chai, Manjie Zhang et al. · 2025 · Open Research (University of Surrey)
84. A structural perspective on the design of decoy immune modulators
    Swetha Lankipalli, Udupi Anantharamachar Ramagopal · 2021 · Pharmacological Research
85. Fluorene methoxycarbonyl-PEG-deferoxamine conjugates “hitchhike” with albumin in situ for iron overload therapy
    Linyi Xu, Rou Guan, Bohong Yu, Yicheng Li, Hongzhuo Liu, Yiguo Jiang · 2022 · International Journal of Pharmaceutics
86. Does Risk of Hyperhomocysteinemia Depend on Thiol-Disulfide Exchange Reactions of Albumin and Homocysteine?
    Lucia Coppo, Simona Scheggi, Graziella DeMontis, Raffaella Priora, Simona Frosali, Antonios Margaritis, Domenico Summa, Danila Di Giuseppe, Monica Ulivelli, Paolo Di Simplicio · 2022 · Antioxidants and Redox Signaling
87. Megalin Orchestrates FcRn Endocytosis and Trafficking
    Eileen Dahlke, Yaman Anan, Lea Maximiliane Klie, Ariane Elisabeth Hartkopf, Franziska Theilig · 2022 · Cells
88. Probing the Binding Mechanism of Acylated Peptides to Human Serum Albumin
    Haitao Hu, Anthony S. Ransdell, Hongchang Qu, Jim D. Durbin, Francisco A. Valenzuela, Selene Hernandez-Buquer, Malgorzata D. Gonciarz · 2023 · ACS Chemical Biology
89. An Albumin-Holliday Junction Biomolecular Modular Design for Programmable Multifunctionality and Prolonged Circulation
    Anders Dinesen, Veronica L. Andersen, Marwa Elkhashab, Diego Pilati, Pernille Bech, Elisabeth Fuchs, Torbjørn R. Samuelsen, Alexander Winther, Yunpeng Cai, Anders Märcher et al. · 2024 · Bioconjugate Chemistry
90. The Role of IgG in Immune Responses
    Jeanette H.W. Leusen, Falk Nimmerjahn · 2013 · Springer eBooks
91. Cutis laxa for diagnosis of γ1‐heavy‐chain deposition disease: Report of four cases
    Nathalie Chavarot, Maxime Battistella, Marguerite Vignon, Marine Baron, Sophie Girerd, Marie Jachiet, Bouchra Asli, Lionel Galicier, Marion Malphettes · 2018 · The Journal of Dermatology
92. Potential limits of AAV‐based gene therapy with the use of new transgenes expressing factor IX fusion proteins
    Sandra Le Quellec, Allison P. Dane, Nathalie Enjolras, Jenny McIntosh, Cecilia Rosales, Claude Négrier, Amit Chunilal Nathwani · 2018 · Haemophilia
93. Evaluation of the possible hepatotoxic and nephrotoxic potentials of the Averrhoa carambola juice extract in female albino rats
    Patrick E. Aba, Augustus Uchechukwu Amadi · 2019 · Journal of Basic and Clinical Physiology and Pharmacology
94. Kinetic and structural characterization of therapeutic albumin chemical functionalization using complementary mass spectrometry techniques
    Rabah Gahoual, Gérard Bolbach, Ikram Ould-Melha, Gilles Clodic, Yannis‐Nicolas François, Daniel Scherman, Nathalie Mignet, Pascal Houzé · 2020 · Journal of Pharmaceutical and Biomedical Analysis
95. Human IgG1 Fc pH-dependent optimization from a constant pH molecular dynamics simulation analysis
    Yee Ying Lim, Theam Soon Lim, Yee Siew Choong · 2020 · RSC Advances
96. The availability of new drugs for hemophilia treatment
    Massimo Morfini, Emanuela Marchesini · 2020 · Expert Review of Clinical Pharmacology
97. AlbuCORE: an albumin-based molecular scaffold for multivalent biologics design
    Mário Sanches, Igor D’Angelo, María Jaramillo, Jason Baardsnes, John C. Zwaagstra, Joe Schrag, Ian C. Schoenhofen, Mauro Acchione, Samuel O. Lawn, Grant Wickman et al. · 2020 · mAbs
98. Dynamics of intracellular neonatal Fc receptor–ligand interactions in primary macrophages using biophysical fluorescence techniques
    Andreas Pannek, Fiona J. Houghton, Anne M. Verhagen, Steven K. Dower, Elizabeth Hinde, Paul A. Gleeson · 2021 · Molecular Biology of the Cell
99. Engineering Antibodies for Cancer Therapy
    Lisa E. Goldsmith, Matthew K. Robinson · 2011 · Cell engineering
100. Bio‐reduction of Redox‐Sensitive Albumin Conjugates in FcRn‐Expressing Cells
     Lorine Brülisauer, Gina Valentino, Sakura Morinaga, Kübra Cam, Jens T. Bukrinski, Marc Andre Gauthier, Jean‐Christophe Leroux · 2014 · Angewandte Chemie